REGN
Regeneron Pharmaceuticals Inc
stockNASDAQ
Market OpenOct 29, 2026 10:31:35 AM EDT
820.23USD+0.856%(+6.96)135,228
Pre-marketOct 29, 2026 9:25:30 AM EDT
827.20USD+1.713%(+13.93)
REGN Financials
In Q2 FY 2026 (ended ), Regeneron Pharmaceuticals Inc (REGN) reported revenue of $4.29B, net income of $1.3B, operating cash flow of $813M, and assets of $41.73B.
Loading financial statements…